Dr. Todd Malan - Stem Cell Therapy
Call or Text
Dr. Todd Malan - Stem Cell Therapy
Call or Text Now:
(480) 998-7999
Schedule Appointment
DR. TODD MALAN - STEM CELL THERAPY
Dr. Todd Malan - Stem Cell Therapy Doctor
Dr. Todd Malan is considered one of the true pioneers of fat derived stem cell therapies in the USA. In October of 2009, Dr. Malan was the first U.S. physician to utilize adipose or fat derived stem cells for soft tissue reconstruction. He has described his techniques and experience as an author in two medical textbooks as well as having presented at dozens of stem cell conferences worldwide.
Dr. Malan has been pivotal in developing safe protocols for stem cell harvesting and deployment for regenerative medicine and has trained hundreds of physicians worldwide in the safe and effective use of adipose derived stem cells. Dr. Malan began to seek out ways to utilize adipose stem cells for regenerative applications after a close family member was diagnosed with multiple sclerosis (MS). Dr. Malan now divides his practice time into cosmetic stem cell procedures and regenerative medicine research for patients with chronic disease and degenerative disorders.
Dr. Malan frequently works in Europe with other global Stem Cell experts and has been the first to introduce several new stem cell technologies in the US. Dr. Malan is a nationally recognized speaker and educator on advanced body sculpting, and stem cell enriched fat transfer. He is a frequent guest speaker for organizations such as the American Academy of Cosmetic Surgery, American Society of Cosmetic Breast Surgery and the American Academy of Anti-Aging Medicine. Dr. Malan also has been featured many times in the media for his advances in stem cell assisted fat transfer techniques.
Dr. Malan received his Bachelors Degree from Brigham Young University and continued his studies at the University of Arizona College of Medicine where he graduated in the top 10 percent of his class in May 1993. He completed his residency at Walter Reed Army and Bethesda Naval hospitals in Washington, D.C. Dr. Malan is board certified in Obstetrics and Gynecology. Presently, Dr. Malan is an associate of the American Academy of Cosmetic Surgeons, founding member of the American Academy of Cosmetic Physicians, member of the California Academy of Cosmetic Surgery and American Academy of Anti-Aging Medicine.
First Name*
Last Name*
Phone*
Email*
Reason for Appointment
I prefer to be contacted by:*
---
Are you a new patient?*
---
I would like to schedule a visit:*
---
What time of day would you prefer?*
---
What day of the week would you like to schedule your consultation?*
MondayTuesdayWednesdayThursdayFriday
Sign up for a newsellter
QUICK LINKS
MEET DR. MALAN
MEDIA
EVENTS & ENGAGEMENTS
STEM CELLS AND THE FDA
STEM CELL FAQS
LEAVE A REVIEW
DR. MALAN IN THE NEWS
Center For Regenerative Cell Medicine
7425 E Shea Blvd #104
Scottsdale, AZ 85260
New Patients
(480) 998-7999
Schedule Appointment
Monday - Friday 8:30am - 4:30pm
Sitemap Privacy Policy Terms of Use Accessibility
Quantum Materials Corp. (QTMM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....
Continue Reading
Understanding Alfa Laval's Third Quarter Surge Alfa Laval's third quarter report isn't just another financial document; it's a reflection of the volatility and unpredictable nature of the engineering sector. Sure, revenues and earnings have shot up, but there's a hint of caution as we steer into the fourth quarter. Order intake—a term that gives every investor a reason...
Continue Reading
Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...
Continue Reading
Pizza with a Punch: Irvine's Tifosi Heats Up We've got another chef-driven concept cooking up in Irvine. This time, it's Tifosi Pizza + Trattoria stirring the pot at Centerview. The spot's bringing 'New, New York' style pizza, blending Big Apple boldness with Italian tradition, and tossing in a bit of California flair for good measure. "The main idea is to create...
Continue Reading
Honeywell's Bumpy Ride Rattles Investors Something's brewing over at Honeywell Aerospace, Inc. (NASDAQ:HONA) and it's not your regular cup of joe. Investors, brace yourselves, because a securities fraud class action lawsuit is stacking up against them. With shares plummeting 23.16% in a whirlwind of a market day, it's kind of hard not to get a little riled up, isn't it?...
Continue Reading
Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...
Continue Reading
Getting Set for a Big Move Blue Moon Metals Inc. isn't sitting around with its thumbs in its pockets. The company has made some strides with their Springer Tungsten Mine project in Imlay, Nevada. Let's break down what these folks are up to. Refurbished Up for the Fast Track The rock mover here is the refurbishment of the Springer processing plant. You don't just snap your...
Continue Reading
The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...
Continue Reading
A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...
Continue Reading
EQS Group's Bold Climate Commitments The news hits like a gust of clean air — EQS Group's climate targets are now stamped with the seal of approval from the Science Based Targets initiative (SBTi). This isn't just your typical corporate green pledge: we're talking serious, validated commitments pushing for net-zero emissions by 2050. Decoding EQS Group's Impactful...
Continue Reading
ction End -->
Top 5 Most Recently Viewed Articles
AI Innovations Driving Digital Transformation in Oil & Gas The oil and gas industry is experiencing significant growth fueled by digital transformation. Investments and partnerships have become pivotal, driving a market estimated to increase by USD 56.4 billion from 2025 to 2029. This transformation is underpinned by advancements in technology, particularly artificial...
Continue Reading
Fintech's New Era of Growth and Innovation Recent insights reveal that the fintech industry is experiencing remarkable growth and transformative changes. This revival is highlighted in a report from knowledgeable industry analysts who indicate that this sector is on the brink of substantial disruption through innovative technologies and calculated expansion strategies,...
Continue Reading
Greystone Logistics Announces Stock Buybacks In a significant move to strengthen its financial foundation, Greystone Logistics, Inc. (OTCQB: GLGI), known for its innovative approach to sustainable manufacturing, has successfully completed the redemption of $5 million Preferred Stock. Additionally, the company has repurchased an impressive 620,052 shares of its common...
Continue Reading
Important Actions for Caribou Biosciences Investors In the dynamic landscape of securities litigation, investors of Caribou Biosciences, Inc. (NASDAQ: CRBU) are facing a critical deadline. With the date of lead plaintiff designation approaching, it is essential for affected individuals to understand their rights and the necessary steps they can take to protect their...
Continue Reading
Mattr Welcomes Jane Skoblo as New Director Mattr Corp. (TSX: MATR) is excited to announce the addition of Jane Skoblo to its Board of Directors. This move is part of a strategic transitional plan as the company prepares for upcoming changes in leadership. Skoblo, who officially stepped into her role on August 13, 2025, will take an active part in the Audit and...
Continue Reading